{"id":9487,"date":"2024-08-09T18:51:54","date_gmt":"2024-08-09T10:51:54","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9487"},"modified":"2024-09-02T16:34:07","modified_gmt":"2024-09-02T08:34:07","slug":"the-board-of-directors-approved-q2-2024-consolidated-financial-statements","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-q2-2024-consolidated-financial-statements\/","title":{"rendered":"The Board of Directors approved Q2 2024 consolidated financial statements."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a02<\/td>\nDate of announcement<\/td>\n2024\/08\/09<\/td>\nTime of announcement<\/td>\n18:51:07<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved Q2 2024\r\nconsolidated financial statements.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2024\/08\/09<\/td>\nTo which item it meets<\/td>\nparagraph 31<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of submission to the board of directors or \r\n  approval by the board of directors:2024\/08\/09\r\n2.Date of approval by the audit committee:\r\n  2024\/08\/09\r\n3.Start and end dates of financial reports or \r\n  annual self-assessed financial information of\r\n  the reporting period(XXXX\/XX\/XX~XXXX\/XX\/XX):\r\n  2024\/01\/01~2024\/06\/30\r\n4.Operating revenue accumulated from 1\/1 to end\r\n  of the period (thousand NTD):4,201,550\r\n5.Gross profit (loss) from operations accumulated\r\n  from 1\/1 to end of the period (thousand NTD):\r\n  837,147\r\n6.Net operating income (loss) accumulated from 1\/1\r\n  to end of the period(thousand NTD):339,014\r\n7.Profit (loss) before tax accumulated from 1\/1 to\r\n  end of the period(thousand NTD):582,077\r\n8.Profit (loss) accumulated from 1\/1 to end of the\r\n  period (thousand NTD):489,335\r\n9.Profit (loss) during the period attributable to \r\n  owners of parent accumulated from 1\/1 to end of \r\n  the period (thousand NTD):405,554\r\n10.Basic earnings (loss) per share accumulated from\r\n   1\/1 to end of the period (NTD):2.61\r\n11.Total assets end of the period (thousand NTD):\r\n   17,690,457\r\n12.Total liabilities end of the period (thousand NTD):\r\n   6,845,229\r\n13.Equity attributable to owners of parent end of the \r\n   period(thousand NTD):8,643,910\r\n14.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a02 Date of announcement 2024\/08\/09 Time of announcement 18:51:07 Subject The Board of Directors approved Q2 2024 consolidated financial statements. Date of events 2024\/08\/09 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2024\/08\/09 2.Date of approval by the audit …<\/p>\n
  The Board of Directors approved Q2 2024 consolidated financial statements.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[102,72],"tags":[],"class_list":["post-9487","post","type-post","status-publish","format-standard","hentry","category-material-information","category-investors"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9487"}],"version-history":[{"count":3,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9487\/revisions"}],"predecessor-version":[{"id":9490,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9487\/revisions\/9490"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}